Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04410913 · ClinicalTrials.gov registry record · Phase 2
Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
A Phase 2 study of Alcohol Use Disorder, sponsored by Keith Heinzerling.
- Active
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04410913 is a Phase 2 study of Alcohol Use Disorder that is active but no longer recruiting, run by Keith Heinzerling. The registered enrollment target is 20 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04410913, a Phase 2 study of Alcohol Use Disorder, is active but no longer recruiting, sponsored by Keith Heinzerling.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Twenty participants, age 18 or older, who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for moderate to severe Alcohol Use Disorder will be randomized to open-label psilocybin (25 mg) therapy with the Visual Healing Set and Setting platform (N=10) versus psilocybin (25 mg) with a standard Set and Setting platform (N=10). The purpose of this study is to evaluate the feasibility, safety, and tolerability of adding Visual Healing, a nature-themed virtual immersive program, to psilocybin-assisted therapy among participants with alcohol use disorder.
Conditions Studied
Interventions
- DRUG Psilocybin plus Visual Healing Set and Setting
- DRUG Psilocybin plus Standard Set and Setting
Study Locations (1)
California
- Pacific Treatment & Research in Psychedelics - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-02-18 |
| Est. Completion | 2023-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04410913
The ClinicalTrials.gov registry entry for NCT04410913 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (94% lower). The listed sponsor is Keith Heinzerling, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Psilocybin plus Visual Healing Set and Setting is the first listed.
NCT04410913 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04410913 about?
NCT04410913 is a clinical study titled "Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder". Twenty participants, age 18 or older, who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for moderate to severe Alcohol Use Disorder will be randomized to open-label psilocybin (25 mg) therapy with the Visual Healing Set and Setting platform (N=10) versus psilocybin (25 ...
What is the current status of trial NCT04410913?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2021-02-18. Estimated completion is 2023-02.
What conditions does trial NCT04410913 study?
This clinical trial studies the following conditions: Alcohol Use Disorder.
What interventions are being tested in trial NCT04410913?
The interventions under investigation include: Psilocybin plus Visual Healing Set and Setting (DRUG), Psilocybin plus Standard Set and Setting (DRUG).
Who is sponsoring clinical trial NCT04410913?
This trial is sponsored by Keith Heinzerling, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04410913 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
RECRUITING · Phase 2
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
COMT Inhibition Among Individuals With Comorbid AUD/ADHD
RECRUITING · Phase 2
-
Semaglutide Therapy for Alcohol Reduction (STAR)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.